{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T19:40:07Z","timestamp":1750362007500,"version":"3.41.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Childhood cancer survivors (CCS) often develop late complications after their primary disease is cured. Cardiovascular disease is one of the most frequent and serious complications that significantly affects prognosis and quality of life. Early detection and appropriate intervention are expected to improve their prognosis. However, the risk factors for late cardiotoxicity in CCS are not well defined, and biomarkers that can detect cardiac dysfunction prior to the development of heart failure have not yet been established.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Medical records of childhood hematologic cancer survivors referred to our department for transitional care between January 2016 and October 2023 were reviewed for this cross-sectional study. The relationships between the most recent cardiac function at the review and history of cancer treatment were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>This study included 34 patients and the median elapsed time since cancer diagnosis was 16.5 years (range, 5\u201330 years). None of the patients had symptomatic cardiac complications. The E\/e\u2019 ratio was significantly higher in survivors with a history of hematopoietic stem cell transplantation (HSCT) than in those who did not undergo HSCT (median, 8.4% vs. 6.25%, <jats:italic>P<\/jats:italic>\u2009=\u20090.040), while no intergroup differences were observed in ejection fraction (EF), global longitudinal strain (GLS), or the brain natriuretic protein (BNP) level. In addition, the E\/e\u2019 ratio was positively correlated with years elapsed since cancer diagnosis (\u03c1\u2009=\u20090.38, P\u2009=\u20090.034). While there was no clear correlation between years since cancer diagnosis and the BNP level in the overall cohort, a strong correlation was found in patients with a history of HSCT (\u03c1\u2009=\u20090.73; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). No significant differences were observed in EF, E\/e\u2019 ratio, GLS, and BNP level by cumulative anthracycline dose or history of chest irradiation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In this study, no patient had late symptomatic cardiac complications. However, in those who had survived for a long time since their cancer diagnosis, particularly those with a history of HSCT, there were significant elevations in the E\/e\u2019 ratio and the BNP level. Continuous follow-up is required to determine whether these abnormalities lead to symptomatic cardiotoxicity and whether they serve as useful markers for the early detection of cardiac complications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40959-025-00354-1","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T07:13:12Z","timestamp":1750317192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Importance of E\/e\u2019 and BNP for early detection of late cardiotoxicity in long-term follow-up of childhood hematologic cancer survivors: a retrospective cross-sectional study"],"prefix":"10.1186","volume":"11","author":[{"given":"Yuri","family":"Okazoe-Hirakawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimikazu","family":"Yakushijin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakuya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Nose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Kimbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Nagatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiji","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Inui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Funakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Kiyota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Hatazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"354_CR1","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572\u201382.","journal-title":"N Engl J Med"},{"issue":"21","key":"354_CR2","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1200\/JCO.2017.77.0180","volume":"36","author":"W Landier","year":"2018","unstructured":"Landier W, Skinner R, Wallace WH, et al. Surveillance for late effects in childhood Cancer survivors. J Clin Oncol. 2018;36(21):2216\u201322.","journal-title":"J Clin Oncol"},{"issue":"12","key":"354_CR3","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s11912-022-01329-6","volume":"24","author":"E Bennati","year":"2022","unstructured":"Bennati E, Girolami F, Spaziani G, et al. Cardio-Oncology in childhood: state of the Art. Curr Oncol Rep. 2022;24(12):1765\u201377.","journal-title":"Curr Oncol Rep"},{"issue":"25","key":"354_CR4","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1200\/JCO.2007.10.9777","volume":"25","author":"JR Carver","year":"2007","unstructured":"Carver JR, Shapiro CL, Ng A, et al. American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25(25):3991\u20134008.","journal-title":"J Clin Oncol"},{"issue":"1","key":"354_CR5","first-page":"1","volume":"9","author":"C Auberle","year":"2023","unstructured":"Auberle C, Lenihan D, Gao F, et al. Late cardiac events after allogeneic stem cell transplant: incidence, risk factors, and impact on overall survival. Cardiooncology. 2023;9(1):1.","journal-title":"Cardiooncology"},{"issue":"1","key":"354_CR6","first-page":"149","volume":"10","author":"M Hegazy","year":"2023","unstructured":"Hegazy M, Ghaleb S, Das BB. Diagnosis and management of Cancer Treatment-Related cardiac dysfunction and heart failure in children. Child (Basel). 2023;10(1):149.","journal-title":"Child (Basel)"},{"issue":"5","key":"354_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.bbmt.2016.01.023","volume":"22","author":"EJ Chow","year":"2016","unstructured":"Chow EJ, Anderson L, Baker KS, et al. Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: A children\u2019s oncology group report. Biol Blood Marrow Transpl. 2016;22(5):782\u201395.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"354_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11764-020-00920-9","volume":"15","author":"M Otth","year":"2021","unstructured":"Otth M, Denzler S, Koenig C, et al. Transition from pediatric to adult follow-up care in childhood cancer survivors-a systematic review. J Cancer Surviv. 2021;15(1):151\u201362.","journal-title":"J Cancer Surviv"},{"issue":"25 Pt A","key":"354_CR9","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","volume":"63","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan P, Poulin F, Lim KD, et al. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63(25 Pt A):2751\u201368.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"354_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/jha2.586","volume":"4","author":"M Watanabe","year":"2023","unstructured":"Watanabe M, Yakushijin K, Tanaka H, et al. Global longitudinal strain is superior to ejection fraction for long-term follow-up after allogeneic hematopoietic stem cell transplantation. EJHaem. 2023;4(1):192\u20138.","journal-title":"EJHaem"},{"issue":"41","key":"354_CR11","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international Cardio-Oncology society (IC-OS). Eur Heart J. 2022;43(41):4229\u2013361.","journal-title":"Eur Heart J"},{"issue":"3","key":"354_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48(3):452\u20138.","journal-title":"Bone Marrow Transpl"},{"issue":"10","key":"354_CR13","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.jcmg.2009.05.013","volume":"2","author":"K Kusunose","year":"2009","unstructured":"Kusunose K, Yamada H, Nishio S, et al. Clinical utility of single-beat e\/e\u2019 obtained by simultaneous recording of flow and tissue doppler velocities in atrial fibrillation with preserved systolic function. JACC Cardiovasc Imaging. 2009;2(10):1147\u201356.","journal-title":"JACC Cardiovasc Imaging"},{"key":"354_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0002-9149(02)03122-3","volume":"91","author":"DA Tighe","year":"2003","unstructured":"Tighe DA, Vinch CS, Hill JC, Meyer TE, et al. Influence of age on assessment of diastolic function by doppler tissue imaging. Am J Cardiol. 2003;91:254\u20137.","journal-title":"Am J Cardiol"},{"issue":"17","key":"354_CR15","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1161\/CIR.0b013e3182a88099","volume":"128","author":"SE Lipshultz","year":"2013","unstructured":"Lipshultz SE, Adams MJ, Colan SD, et al. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American heart association. Circulation. 2013;128(17):1927\u201395.","journal-title":"Circulation"},{"key":"354_CR16","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1200\/JCO.2005.12.121","volume":"23","author":"SE Lipshultz","year":"2005","unstructured":"Lipshultz SE, Lipsitz SR, Sallan SE, et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol. 2005;23:2629\u201336.","journal-title":"J Clin Oncol"},{"issue":"12","key":"354_CR17","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1200\/JCO.2013.51.1055","volume":"32","author":"GT Armstrong","year":"2014","unstructured":"Armstrong GT, Kawashima T, Leisenring W, et al. Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol. 2014;32(12):1218\u201327.","journal-title":"J Clin Oncol"},{"issue":"1\u20132","key":"354_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ppedcard.2014.09.003","volume":"36","author":"GT Armstrong","year":"2014","unstructured":"Armstrong GT, Ross JD. Late cardiotoxicity in aging adult survivors of childhood Cancer. Prog Pediatr Cardiol. 2014;36(1\u20132):19\u201326.","journal-title":"Prog Pediatr Cardiol"},{"issue":"4","key":"354_CR19","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/CIRCRESAHA.121.319902","volume":"130","author":"H Ji","year":"2022","unstructured":"Ji H, Kwan AC, Chen MT, et al. Sex differences in myocardial and vascular aging. Circ Res. 2022;130(4):566\u201377.","journal-title":"Circ Res"},{"key":"354_CR20","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1200\/JCO.2001.19.13.3163","volume":"19","author":"AC Mertens","year":"2001","unstructured":"Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the childhood Cancer survivor study. J Clin Oncol. 2001;19:3163\u201372.","journal-title":"J Clin Oncol"},{"issue":"29","key":"354_CR21","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","volume":"31","author":"GT Armstrong","year":"2013","unstructured":"Armstrong GT, Oeffinger KC, Chen Y, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013;31(29):3673\u201380.","journal-title":"J Clin Oncol"},{"issue":"2","key":"354_CR22","doi-asserted-by":"publisher","first-page":"e29473","DOI":"10.1002\/pbc.29473","volume":"69","author":"K Carpenter","year":"2022","unstructured":"Carpenter K, Scavotto M, McGovern A, et al. Early parental knowledge of late effect risks in children with cancer. Pediatr Blood Cancer. 2022;69(2):e29473.","journal-title":"Pediatr Blood Cancer"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-025-00354-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-025-00354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T19:02:54Z","timestamp":1750359774000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiooncologyjournal.biomedcentral.com\/articles\/10.1186\/s40959-025-00354-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1186\/s40959-025-00354-1","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Kobe University Hospital (No. B240214). The requirement for informed consent was waived due to the retrospective nature of the study. The patients who participated in this study were offered the opportunity to opt-out.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}